Sepracor (SEPR) over all volatility low at 48 into disappointing data
Sepracor (Nasdaq: SEPR) : Sepracor is recently trading at $15 in pre-open trading, below its close of $17.89. SEPR announced that SEP-225289 failed to meet its primary endpoint in a pivotal Phase 2 trial in patients with major depressive disorder. SEPR also announced the FDA has put two Lunesta pediatric studies on hold due to concerns about non-clinical data that could be relevant to the use of Lunesta in children. SEPR over all option implied volatility of 48 is below its six-month average of 57, according to Track Data. Paul Foster
You May Also Be Interested In
- Morgan Stanley (MS) Shares Pressured on Questionable Facebook (FB) Tactics; Hits Fresh 6-Month Low
- Biosante Pharma (BPAX) Volatility Elevated on Trader Profit Taking
- Stocks with implied volatility movement; BTU CNX
Create E-mail Alert Related Categories
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
